Agios Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to the research and advancement of new treatments, specifically targeting cellular metabolism and related biological fields. The company's offerings include PYRUKYND (mitapivat), a medication designed to activate both wild-type and various mutated pyruvate kinase (PK) enzymes, used in the management of hemolytic anemias. Additionally, Agios is developing AG-946, which is currently undergoing Phase I clinical studies for treating hemolytic anemias and other diseases. Established in 2007, the company's main office is located in Cambridge, Massachusetts.
Show more...
FAQ
Agios Pharmaceuticals 今天的股價是多少?▼
AGIO 目前價格為 $37.58 USD,過去 24 小時上漲了 +1.35%。在圖表上更密切關注 Agios Pharmaceuticals 股價表現。
Agios Pharmaceuticals 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Agios Pharmaceuticals 的股票以代號 AGIO 進行交易。
Agios Pharmaceuticals 的股價在上漲嗎?▼
AGIO 股票較上週下跌 -1.21%,本月上漲 +32.84%,過去一年 Agios Pharmaceuticals 上漲 +4.19%。
Agios Pharmaceuticals 的市值是多少?▼
今天 Agios Pharmaceuticals 的市值為 2.23B
Agios Pharmaceuticals 下一次財報日期是什麼時候?▼
Agios Pharmaceuticals 將於 July 30, 2026 公布下一次財報。
Agios Pharmaceuticals 上一季度的財報如何?▼
AGIO 上一季度的財報為每股 -1.69 USD,預估為 -1.8 USD,帶來 +6.29% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Agios Pharmaceuticals 去年的營收是多少?▼
Agios Pharmaceuticals 去年的營收為 54.03MUSD。
Agios Pharmaceuticals 去年的淨利是多少?▼
AGIO 去年的淨收益為 -412.78MUSD。
Agios Pharmaceuticals 有多少名員工?▼
截至 July 06, 2026,公司共有 486 名員工。
Agios Pharmaceuticals 位於哪個產業?▼
Agios Pharmaceuticals從事於Health & Wellness產業。
Agios Pharmaceuticals 何時完成拆股?▼
Agios Pharmaceuticals 最近沒有進行任何拆股。
Agios Pharmaceuticals 的總部在哪裡?▼
Agios Pharmaceuticals 的總部位於 美國 的 Cambridge。